Targeting autophagy: a novel anticancer strategy with therapeutic implications for imatinib resistance
Jennifer S Carew1, Steffan T Nawrocki1, Francis J Giles1, John L Cleveland21The CTRC Institute for Drug Development, University of Texas Health Science Center San Antonio, San Antonio, TX, USA; 2The Department of Cancer Biology, The Scripps Research Institute, Jupiter, FL, USAAbstract: Autophagy is...
Main Authors: | Jennifer S Carew, Steffan T Nawrocki, Francis J Giles, John L Cleveland |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2008-06-01
|
Series: | Biologics : Targets & Therapy |
Online Access: | http://www.dovepress.com/targeting-autophagy-a-novel-anticancer-strategy-with-therapeutic-impli-a1726 |
Similar Items
-
Therapeutic Targeting of Autophagy for Renal Cell Carcinoma Therapy
by: Trace M. Jones, et al.
Published: (2020-05-01) -
Autophagy: New Insights into Its Roles in Cancer Progression and Drug Resistance
by: Steffan T. Nawrocki, et al.
Published: (2020-10-01) -
Nilotinib: optimal therapy for patients with chronic myeloid leukemia and resistance or intolerance to imatinib
by: Ronan Swords, et al.
Published: (2009-03-01) -
Moving beyond hydroxychloroquine: the novel lysosomal autophagy inhibitor ROC-325 shows significant potential in preclinical studies
by: Trace M. Jones, et al.
Published: (2019-11-01) -
Autophagy as a target for cancer therapy: new developments
by: Carew JS, et al.
Published: (2012-10-01)